相关产品推荐更多 >

牛生长分化因子8(MSTN)ELISA试剂盒【Bovine Growth/differentiation factor 8(MSTN) ELISA Kit】
¥3000
大鼠低密度脂蛋白(LDL)ELISA试剂盒【Rat low density lipoprotein,LDL ELISA Kit】
¥2500
人类风湿因子(RF)抗体(IgA)ELISA试剂盒【Human rheumatoid factor (RF) antibody (IgA) ELISA Kit】
¥2500
大鼠前列环素(PGI2)ELISA试剂盒【Rat prostacycline,PGI2 ELISA Kit】
¥2500
小鼠胰岛素(INS)ELISA试剂盒【Mouse Insulin,INS ELISA Kit】
¥2500
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商:
武汉研升生物科技有限公司
- 检测范围:
3.9pg/ml
- 检测方法:
Sandwich
- 适应物种:
Canis lupus familiaris (Dog) (Canis familiaris)
- 样本:
serum, plasma, tissue homogenates
- 灵敏度:
Others
- 规格:
96T/48T
| 规格: | 96T | 产品价格: | ¥4200.0 |
|---|---|---|---|
| 规格: | 48T | 产品价格: | ¥3000.0 |
| Product Name |
Dog Interleukin-1 receptor antagonist protein(IL1RN) ELISA Kit |
| Chinese Name |
犬白介素1受体拮抗剂蛋白(IL1RN)ELISA Kit |
| Code |
CSB-EL011628DO |
| Alternative Names |
IL1RNInterleukin-1 receptor antagonist protein ELISA Kit; IL-1RN ELISA Kit; IL-1ra ELISA Kit; IRAP ELISA Kit; IL1 inhibitor ELISA Kit |
| Target Name |
interleukin 1 receptor antagonist |
| Abbreviation |
IL1RN |
| Uniprot No. |
Q9BEH0 |
| Species |
Canis lupus familiaris (Dog) (Canis familiaris) |
| Sample Types |
serum, plasma, tissue homogenates |
| Detection Range |
15.6pg/ml-1000pg/ml |
| Sensitivity |
3.9pg/ml |
| Assay Principle |
quantitative |
| Measurement |
Sandwich |
| Assay Time |
1-5h |
| Sample Volume |
50-100ul |
| Detection Wavelength |
450nm |
| Research Area |
Others |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Upregulating G Protein-Coupled Receptors with Receptor Antagonists
The phenomenon of antagonist-induced receptor upregulation is common to many G protein-coupled receptors (GPCRs) such as adrenergic, muscarinic, opioid, cannabinoid, histamine, GABA(B), serotonin, and dopamine receptors
Detecting the Role of Arrestins in G Protein-Coupled Receptor Regulation
to the response evaluated and agonist and antagonist become terms that reflect a particular condition of the experimental or physiological output. Therefore, the composition of the receptor’s immediate environment may determine activation
reduction in ischemic cell death seen when IL-1 receptor antagonist (IL-1ra) is administered. Mechanisms of IL-1 action remain largely unknown, but they may involve complex effects on many cells including microglia, astrocytes, neurons, and endothelial cells
技术资料暂无技术资料 索取技术资料





